吲达帕胺合氨氯地平治疗高血压合并冠心病的疗效

Efficacy of daplamide combined with amlodipine in the treatment of hypertension complicated with coronary heart disease

ES评分 0

DOI 10.12208/j.ijcr.20220187
刊名
International Journal of Clinical Research
年,卷(期) 2022, 6(4)
作者
作者单位

清镇市新店镇中心卫生院 贵州清镇 ;

摘要
研究高血压合并冠心病采取吲达帕胺、氨氯地平一起治疗产生的作用。方法 实验对象:58例高血压合并冠心病患者。实验时间:2020年1月到2021年1月。实验分组方式:随机数表方式。实验分组类别:对照组实施氨氯地平单独治疗,为29例;观察组实施吲达帕胺、氨氯地平一起治疗,为29例。结果 观察组治疗后总有效率显著较高,观察组治疗后收缩压、舒张压明显降低,差异具有统计学意义,(P<0.05)。观察组和对照组不良反应发生率均较低,无明显差异,(P>0.05)。结论 吲达帕胺、氨氯地平一起应用于此次病证中治疗能够稳定血压,治疗效果较明显,安全性较高,值得临床重视。
Abstract
Objective To study the effect of indapamide and amlodipine on hypertension complicated with coronary heart disease. Methods: Subjects: 58 patients with hypertension complicated with coronary heart disease. Experiment time: January 2020 to January 2021. Experimental grouping: random number table. Experimental grouping category: 29 cases in the control group were treated with amlodipine alone; In the observation group, 29 cases were treated with indapamide and amlodipine. Results: the total effective rate of the observation group was significantly higher after treatment, and the systolic and diastolic blood pressure of the observation group decreased significantly after treatment (P < 0.05). The incidence of adverse reactions in the observation group and the control group was low, and there was no significant difference (P > 0.05). Conclusion: indapamide and amlodipine can stabilize blood pressure in the treatment of this syndrome, with obvious therapeutic effect and high safety, which is worthy of clinical attention.
关键词
吲达帕胺;氨氯地平;高血压;冠心病;疗效
KeyWord
Indapamide; Amlodipine; Hypertension; Coronary Heart Disease; Curative Effect
基金项目
页码 158-160
  • 参考文献
  • 相关文献
  • 引用本文

穆勤凯*. 吲达帕胺合氨氯地平治疗高血压合并冠心病的疗效 [J]. 国际临床研究杂志. 2022; 6; (4). 158 - 160.

  • 文献评论

相关学者

相关机构